Reaction
Candida Pneumonia reporting signals
As of the last recalculation, Candida Pneumonia appears in 320 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is POLATUZUMAB VEDOTIN (PRR 112.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Polatuzumab Vedotin | 16 | 112.2 | 112.4 |
| Itraconazole | 13 | 75.4 | 75.5 |
| Bendamustine Hcl | 16 | 70.6 | 70.7 |
| Amikacin | 14 | 55.8 | 55.8 |
| Cytarabine | 31 | 37.1 | 37.1 |
| Dronedarone | 5 | 32.4 | 32.4 |
| Carfilzomib | 9 | 21.3 | 21.3 |
| Daratumumab | 11 | 18.5 | 18.5 |